In a REGISTRY cohort, including patients with prodromal or symptomatic Huntington’s Disease (HD), and persons at risk of developing HD, the Stroop test is used as a tool to assess disease severity and progression. The aim is to determine the best test to describe the progress of Huntington’s Disease.

Beteiligte Wissenschaftler:
Dr. rer. medic. Dipl.-Math. R. Koch

Dr. Ralf Reilmann (Klinik und Poliklinik für Neurologie, UK Münster)